Cargando…
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Genomic screening of cancer patients for predisposing variants is traditionally based on age at onset, family history and type of cancer. Whereas the clinical guidelines have proven efficient in identifying families exhibiting classical attributes of hereditary cancer, the frequency of patients with...
Autores principales: | Bertelsen, Birgitte, Tuxen, Ida Viller, Yde, Christina Westmose, Gabrielaite, Migle, Torp, Mathias Husted, Kinalis, Savvas, Oestrup, Olga, Rohrberg, Kristoffer, Spangaard, Iben, Santoni-Rugiu, Eric, Wadt, Karin, Mau-Sorensen, Morten, Lassen, Ulrik, Nielsen, Finn Cilius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588611/ https://www.ncbi.nlm.nih.gov/pubmed/31263571 http://dx.doi.org/10.1038/s41525-019-0087-6 |
Ejemplares similares
-
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
por: Ahlborn, Lise Barlebo, et al.
Publicado: (2018) -
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
por: Viller Tuxen, Ida, et al.
Publicado: (2019) -
Application of cell-free DNA for genomic tumor profiling: a feasibility study
por: Ahlborn, Lise B., et al.
Publicado: (2019) -
A Comparison of Tools for Copy-Number Variation Detection in Germline Whole Exome and Whole Genome Sequencing Data
por: Gabrielaite, Migle, et al.
Publicado: (2021) -
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
por: Eriksen, Martina, et al.
Publicado: (2022)